Christian Wuchter

发表

Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo

B. Dörken, K. Seeger, P. Daniel, 2000, Leukemia.

Efficient elimination of chronic lymphocytic leukaemia B cells by autologous T cells with a bispecific anti-CD19/anti-CD3 single-chain antibody construct

B. Dörken, P. Kufer, C. Wuchter, 2003, Leukemia.

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease.

Martin Dugas, Torsten Haferlach, Wolfgang Kern, 2002 .

Correlation of protein expression and gene expression in acute leukemia

W. Hiddemann, A. Kohlmann, T. Haferlach, 2003, Cytometry. Part B, Clinical cytometry.

Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.

W. Hiddemann, T. Haferlach, S. Schnittger, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Constitutive expression levels of CD95 and Bcl‐2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia

B. Dörken, J. Harbott, M. Schrappe, 2000, British journal of haematology.

Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics

B. Dörken, T. Haferlach, C. Schoch, 1999, Leukemia.

CD95-Mediated Apoptosis in Acute Myeloid Leukemia (AML): Dependence on Maturational Stage and Growth Characteristics in Vitro

B. Dörken, F. Herrmann, C. Wuchter, 1998 .

In vivo expression of survivin and its splice variant survivin‐2B: Impact on clinical outcome in acute myeloid leukemia

B. Dörken, C. Wuchter, W. Ludwig, 2006, International journal of cancer.

High Expression Levels of X-Linked Inhibitor of Apoptosis Protein and Survivin Correlate with Poor Overall Survival in Childhood de Novo Acute Myeloid Leukemia

J. Harbott, C. Wuchter, W. Ludwig, 2004, Clinical Cancer Research.

In vitro susceptibility to dexamethasone- and doxorubicin-induced apoptotic cell death in context of maturation stage, responsiveness to interleukin 7, and early cytoreduction in vivo in childhood T-cell acute lymphoblastic leukemia.

B. Dörken, M. Schrappe, C. Wuchter, 2002, Blood.

lymphoblastic leukemia interleukin 7, and early cytoreduction in vivo in childhood T-cell acute apoptotic cell death in context of maturation stage, responsiveness to In vitro susceptibility to dexamethasone- and doxorubicin-induced

B. Dörken, M. Schrappe, C. Wuchter, 2013 .

In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-κB activity

B. Dörken, C. Scheidereit, Z. Cai, 2001, Leukemia.

Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.

B. Dörken, T. Haferlach, J. Harbott, 2000, Haematologica.

Infant acute lymphoblastic leukemia – combined cytogenetic, immunophenotypical and molecular analysis of 77 cases

A. Borkhardt, A. Teigler‐Schlegel, J. Harbott, 2002, Leukemia.

Apoptotic response to homoharringtonine in human wt p53 leukemic cells is independent of reactive oxygen species generation and implicates Bax translocation, mitochondrial cytochrome c release and caspase activation

B. Dörken, Z. Cai, M. Lin, 2001, Leukemia.